A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

12.7K views

DOI:

10.3791/52009

October 28th, 2014

In This Article

Summary

Here we describe a protocol for generating human induced pluripotent stem cells from peripheral blood using an episome based reprogramming strategy and histone deacetylase inhibitors.

Abstract

This manuscript illustrates a protocol for efficiently creating integration-free human induced pluripotent stem cells (iPSCs) from peripheral blood using episomal plasmids and histone deacetylase (HDAC) inhibitors. The advantages of this approach include: (1) the use of a minimal amount of peripheral blood as a source material; (2) nonintegrating reprogramming vectors; (3) a cost effective method for generating vector free iPSCs; (4) a single transfection; and (5) the use of small molecules to facilitate epigenetic reprogramming. Briefly, peripheral blood mononuclear cells (PBMCs) are isolated from routine phlebotomy samples and then cultured in defined growth factors to yield a highly proliferative erythrocyte progenitor cell population that is remarkably amenable to reprogramming. Nonintegrating, nontransmissible episomal plasmids expressing OCT4, SOX2, KLF4, MYCL, LIN28A, and a p53 short hairpin (sh)RNA are introduced into the derived erythroblasts via a single nucleofection. Cotransfection of an episome that expresses enhanced green fluorescent protein (eGFP) allows for easy identification of transfected cells. A separate replication-deficient plasmid expressing Epstein-Barr nuclear antigen 1 (EBNA1) is also added to the reaction mixture for increased expression of episomal proteins. Transfected cells are then plated onto a layer of irradiated mouse embryonic fibroblasts (iMEFs) for continued reprogramming. As soon as iPSC-like colonies appear at about twelve days after nucleofection, HDAC inhibitors are added to the medium to facilitate epigenetic remodeling. We have found that the inclusion of HDAC inhibitors routinely increases the generation of fully reprogrammed iPSC colonies by 2 fold. Once iPSC colonies exhibit typical human embryonic stem cell (hESC) morphology, they are gently transferred to individual iMEF-coated tissue culture plates for continued growth and expansion.

Introduction

iPSCs are derived from somatic tissues via ectopic expression of a minimal set of pluripotency genes. This technique was initially demonstrated by retroviral transduction of human fibroblasts with OCT4, SOX2, KLF4, and cMYC, which are highly expressed in the pluripotent state1. These transiently expressed “reprogramming factors” alter the target cell’s epigenetic landscape and gene expression profile analogous to human embryonic stem cells2. Once created, iPSCs can potentially be differentiated into any tissue type for further investigation. Thus, they hold promise for use in regenerative medicine, dis....

Access restricted. Please log in or start a trial to view this content.

Protocol

Written informed consent, as approved by the Institutional Review Boards of the Fred Hutchinson Cancer Research Center and the Children"s Hospital of Philadelphia, was obtained from patients before collecting peripheral blood samples. All institutional guidelines were observed. All animal experiments including MEF generation and teratoma formation were approved by the Institutional Animal Care and Use Committee.

1. Ficoll Separation of PBMCS and Expansion of Erythroblasts – Day 0

  1. Dilute peripheral blood 1:1 with Dulbecco’s Phosphate Buffered Saline (DPBS). In a 15 ml round-bottom polystyrene tube, carefully layer....

Access restricted. Please log in or start a trial to view this content.

Results

Three days after nucleofection and before plating the nucleofected cells onto iMEFs, the efficiency of successful nucleofection should be estimated by fluorescence microscopy for eGFP. Figure 1 shows a typical nucleofection experiment with approximately 5-10% of the total cell population expressing eGFP.

Reprogrammed iPSC colonies will begin to appear approximately two weeks after nucleofection. The colonies are generally circular with well-defined borders and may be identifie.......

Access restricted. Please log in or start a trial to view this content.

Discussion

For successful iPSC generation when using this protocol, there are several important caveats that should be considered. During the erythroblast expansion stage, the media change schedule should be strictly followed, as deviations may lead to inefficient stimulation of the target progenitor cell population and a lower efficiency of iPSC generation. It is important to make new expansion medium with fresh dexamethasone with each media change; and the QBSF-60 base medium and dexamethasone should be protected from light durin.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

The authors wish to acknowledge the following grants from the NIH for supporting this research: K08DK082783 (AR), P30DK56465 (BTS), U01HL099993 (BTS), T32HL00715036 (SKS), and K12HL0806406 (SKS); and the JP McCarthy Foundation (AR).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Ficoll-Paque PLUSFisher Scientific45-001-750Store at 4 °C. Warm to room temperature before use.
DPBSLife Technologies14190-250Store at 4 °C.
RPMI 1640Life Technologies11875-093Store at 4 °C.
fetal bovine serum (FBS)Life Technologies10437028Store at -20 °C until needed. Thaw, aliquot, store at 4 °C.
dimethyl sulfoxide (DMSO)Sigma-Aldrich154938Store at room temperature.
QBSF-60 serum-free mediumFisher Scientific50-983-234Store at 4 °C.
penicillin/streptomycinLife Technologies15140122Store at 4 °C.
Cell Line Nucleofector Kit VLonzaVCA-1003Store at 4 °C.
2% gelatin solutionSigma-AldrichG1393Store at 4 °C, liquify in 37 °C water bath before use.
Hank's Balanced Saline Solution (HBSS)Life Technologies14175-103Store at 4 °C.
Dulbecco's Modified Eagle Medium (DMEM)Life Technologies11965-092Store at 4 °C.
Iscove's Modified Dulbecco's Medium (IMDM)Life Technologies12440-061Store at 4 °C.
L-glutamine, 200 mMLife Technologies25030-081Aliquot, freeze at -20 °C.
non-essential amino acids (NEAA), 100XLife Technologies11140-050Store at 4 °C, away from light.
DMEM/Ham's F12, 1:1Fisher ScientificSH30023.02Store at 4 °C.
KnockOut Serum ReplacementLife Technologies10828-028Aliquot, freeze at -20 °C.
sodium pyruvate, 100 mMLife Technologies11360-070Store at 4 °C.
sodium bicarbonate, 7.5%Life Technologies25080094Store at 4 °C.
basic fibroblast growth factor (bFGF)Life TechnologiesPHG0263Make 10 mg/ml stock in DPBS, aliquot, freeze at -20 °C. Once thawed, store at 4 °C.
sodium butyrate Sigma-AldrichB5887-1GMake 2000x stock (400 mM) in DPBS, aliquot, freeze at -20 °C. Once thawed, store at 4 °C.
hES Cell Cloning & Recovery SupplementStemgent01-0014-500Store at -20 °C until needed. Once thawed, store at 4 °C.
ESC-qualified BD matrigelBD Biosciences35-4277Thaw overnight on ice at 4 °C, aliquot into pre-chilled tubes using pre-chilled pipette tips. Store at -20 °C until needed. Thaw at 4 °C, use immediately.
StemSpan SFEM STEMCELL Technologies9650Aliquot, freeze at -20 °C.
ascorbic acid, powderedSigma-AldrichA4403-100MGMake 5 mg/ml stock in DPBS, sterile filter, store at 4 °C.
recombinant human stem cell factor (SCF)R & D Systems255-SC-010Make 100 μg/m stock in SFEM, aliquot, freeze at -20 °C. Once thawed, store at 4 °C.
recombinant human interleukin 3 (IL-3)R & D Systems203-IL-010Make 100 μg/ml stock in SFEM, aliquot, freeze at -20 °C. Once thawed, store at 4 °C.
erythropoietin (EPO)R & D Systems287-TC-500Make 1000 U/ml stock in SFEM, aliquot, freeze at -20 °C. Once thawed, store at 4 °C.
recombinant human insulin-like growth factor 1 (IGF-1)R & D Systems291-G1-200Make 100 μg/ml stock in SFEM, aliquot, freeze at -20 °C. Once thawed, store at 4 °C.
β-mercaptoethanolSigma-AldrichM7522Make 1000x stock (100 mM) in DPBS.
dexamethasoneSigma-AldrichD4902-25MGMake 50x stock (50 μM) in DPBS, sterile filter, store at 4 °C.
SAHA (vorinostat)Cayman Chemical149647-78-9Make 2,000x stock (400 mM) in DPBS, aliquot, freeze at -20 °C. Once thawed, store at 4 °C.
12 well tissue culture plateFisher Scientific08-772-29
15 ml conical tubeSarstedt62553002
1.5 ml Eppendorf tubeFisher Scientific05-408-129
6 well tissue culture plateFisher Scientific08-772-1B
35 mm tisue culture platesBD Biosciences353001
10 ml disposable serological pipettesFisher Scientific13-675-20
5 ml disposable serological pipettesFisher Scientific13-675-22
2 ml disposable serological pipettesFisher Scientific13-675-17
20 μl pipette tips, barrier tipsGenessee24-404
glass Pasteur pipettesFisher Scientific13-678-20D
pipette aidFisher Scientific13-681-15
pCXLE-hOCT3/4-shp53-FAddgene27077
pCXLE-hSKAddgene27078
pCXLE-hULAddgene27080
pCXLE-EGFPAddgene27082
pCXWB-EBNA1Addgene37624

References

  1. Takahashi, K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131 (5), 861-872 (2007).
  2. Koche, R. P., et al. Reprogramming factor expression initiates widespread targeted chromatin remodelin....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Episomal PlasmidsPeripheral Blood Mononuclear CellsErythrocyte Progenitor CellsNucleofectionMouse Embryonic FibroblastsIntegration-Free iPSCsReprogramming MediumFluorescence Microscopy